Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281675830> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4281675830 abstract "Abstract Purpose Impaired adipogenesis is associated with development of insulin resistance and increased risk of type 2 diabetes (T2D). GATA Binding Protein 3 (GATA3) is implicated in impaired adipogenesis and the onset of insulin resistance. Therefore, we hypothesize that inhibition of GATA3 could promote adipogenesis, restore healthy fat distribution, and enhance insulin signaling. Methods BALB/c mice were treated with GATA3 inhibitor (DNAzyme hgd40) over a period of two weeks. Liposomes loaded with DNAzyme, pioglitazone, or vehicle controls were administered subcutaneously every two days, at the right thigh. At the end of the study, adipose tissues were collected and weighed from the site of injection, the opposite side, and the omental tissues. Anti-oxidant enzyme (SOD and catalase) activities were assessed in animals’ sera, and gene expression was measured using well-established protocols. Primary human preadipocytes were treated with DNAzyme hgd40. Cell proliferation, adipogenic capacity, gene expression, and insulin signaling were measured following well-established protocols. Results In vivo GATA3 inhibition promoted adipogenesis at the site of injection and reduced MCP-1 expression. GATA3 inhibition also reduced omental tissue size and PPARγ expression. Additionally, in vitro GATA3 inhibition induced adipogenesis of primary human preadipocytes, and enhanced insulin signaling through reduced expression of p70S6K. Conclusions These findings suggest that modulating GATA3 expression offers a potential therapeutic benefit by correcting impaired adipogenesis, promoting healthy fat distribution, restoring insulin sensitivity and lowering the risk of T2D." @default.
- W4281675830 created "2022-06-13" @default.
- W4281675830 creator A5002014455 @default.
- W4281675830 creator A5009772474 @default.
- W4281675830 creator A5016305270 @default.
- W4281675830 creator A5031859844 @default.
- W4281675830 creator A5040678969 @default.
- W4281675830 creator A5041371218 @default.
- W4281675830 creator A5043766475 @default.
- W4281675830 creator A5047042763 @default.
- W4281675830 creator A5049061075 @default.
- W4281675830 creator A5056478743 @default.
- W4281675830 creator A5057442487 @default.
- W4281675830 creator A5081201704 @default.
- W4281675830 creator A5081688425 @default.
- W4281675830 creator A5085892299 @default.
- W4281675830 date "2022-06-07" @default.
- W4281675830 modified "2023-10-17" @default.
- W4281675830 title "In vivo and in vitro validation of GATA-3 suppression for correcting impaired adipogenesis, restoring insulin sensitivity, and lowering risk of T2D" @default.
- W4281675830 doi "https://doi.org/10.21203/rs.3.rs-1646980/v1" @default.
- W4281675830 hasPublicationYear "2022" @default.
- W4281675830 type Work @default.
- W4281675830 citedByCount "0" @default.
- W4281675830 crossrefType "posted-content" @default.
- W4281675830 hasAuthorship W4281675830A5002014455 @default.
- W4281675830 hasAuthorship W4281675830A5009772474 @default.
- W4281675830 hasAuthorship W4281675830A5016305270 @default.
- W4281675830 hasAuthorship W4281675830A5031859844 @default.
- W4281675830 hasAuthorship W4281675830A5040678969 @default.
- W4281675830 hasAuthorship W4281675830A5041371218 @default.
- W4281675830 hasAuthorship W4281675830A5043766475 @default.
- W4281675830 hasAuthorship W4281675830A5047042763 @default.
- W4281675830 hasAuthorship W4281675830A5049061075 @default.
- W4281675830 hasAuthorship W4281675830A5056478743 @default.
- W4281675830 hasAuthorship W4281675830A5057442487 @default.
- W4281675830 hasAuthorship W4281675830A5081201704 @default.
- W4281675830 hasAuthorship W4281675830A5081688425 @default.
- W4281675830 hasAuthorship W4281675830A5085892299 @default.
- W4281675830 hasBestOaLocation W42816758301 @default.
- W4281675830 hasConcept C122927707 @default.
- W4281675830 hasConcept C126322002 @default.
- W4281675830 hasConcept C134018914 @default.
- W4281675830 hasConcept C150903083 @default.
- W4281675830 hasConcept C171089720 @default.
- W4281675830 hasConcept C207001950 @default.
- W4281675830 hasConcept C2777391703 @default.
- W4281675830 hasConcept C2779306644 @default.
- W4281675830 hasConcept C71924100 @default.
- W4281675830 hasConcept C86803240 @default.
- W4281675830 hasConceptScore W4281675830C122927707 @default.
- W4281675830 hasConceptScore W4281675830C126322002 @default.
- W4281675830 hasConceptScore W4281675830C134018914 @default.
- W4281675830 hasConceptScore W4281675830C150903083 @default.
- W4281675830 hasConceptScore W4281675830C171089720 @default.
- W4281675830 hasConceptScore W4281675830C207001950 @default.
- W4281675830 hasConceptScore W4281675830C2777391703 @default.
- W4281675830 hasConceptScore W4281675830C2779306644 @default.
- W4281675830 hasConceptScore W4281675830C71924100 @default.
- W4281675830 hasConceptScore W4281675830C86803240 @default.
- W4281675830 hasLocation W42816758301 @default.
- W4281675830 hasOpenAccess W4281675830 @default.
- W4281675830 hasPrimaryLocation W42816758301 @default.
- W4281675830 hasRelatedWork W138803513 @default.
- W4281675830 hasRelatedWork W1957106181 @default.
- W4281675830 hasRelatedWork W1986132654 @default.
- W4281675830 hasRelatedWork W2017606817 @default.
- W4281675830 hasRelatedWork W2081564223 @default.
- W4281675830 hasRelatedWork W2082140668 @default.
- W4281675830 hasRelatedWork W2159949415 @default.
- W4281675830 hasRelatedWork W2888559361 @default.
- W4281675830 hasRelatedWork W2913179886 @default.
- W4281675830 hasRelatedWork W4240301311 @default.
- W4281675830 isParatext "false" @default.
- W4281675830 isRetracted "false" @default.
- W4281675830 workType "article" @default.